Nexalin Technology Announces Abstract Accepted For Presentation At 2023 Military Health System Research Symposium Validating The Potential Of Its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device For The Treatment Of Mild Traumatic Brain Injury
Nexalin Technology Announces Abstract Accepted For Presentation At 2023 Military Health System Research Symposium Validating The Potential Of Its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device For The Treatment Of Mild Traumatic Brain Injury
Nexalin Technology 宣布摘要已获准在 2023 年军事卫生系统研究研讨会上发表，验证其非侵入性、基于频率的深脑刺激设备在治疗轻度创伤性脑损伤方面的潜力
Nexalin 科技股份有限公司（“公司” 或 “Nexalin”）（纳斯达克股票代码：NXL，NXLIW）今天宣布，该公司的摘要标题为：“MEG Source Imaging揭示了使用Nexalin...
登录免费看全文
登录/注册
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。